Funding-stage technology disclosures
Record the source, date, permission to use the material, ownership of the claim and any contrary evidence. The associated decision question is: is a technical differentiation claim supported?
Global consulting · Buyer research
Venture Capital Firm
For venture capital firm teams, the immediate decision is to develop technology and ip diligence questions tailored to investment theses. A structured evidence review can make that choice more transparent without implying a legal opinion or a guaranteed commercial outcome.
Technology & IP intelligenceSource-verifiable researchDefined outputs
Decision context
What venture capital firm leaders need to decide
Investors need technical questions tied to a financing decision. A patent count rarely settles whether the product is differentiated, buildable at target cost or dependent on a third party.
Develop technology and IP diligence questions tailored to investment theses. The research brief should identify the actual decision-maker, the point at which a choice becomes difficult to reverse, and the information that could change that choice. Describing an activity as urgent is not enough: the scope needs a decision and a dated review cycle.
In this setting, the crucial distinction is between collecting an impressive quantity of information and producing a reviewable account of what the information means. The output should record what is known, what remains uncertain and which next step will be authorized only after independent evaluation.
Evidence and provenanceINPUT 01 INPUT 02 INPUT 03
Inputs that make the assessment credible
Founder interviews, independent benchmarks, patents and open-source records must be distinguished by evidentiary weight. Valuation and securities conclusions belong to appropriate advisers. The proposed evidence intake below is illustrative; individual engagements require a scope agreed around confidentiality and lawful source access.
Patent and product competitor sources
Record the source, date, permission to use the material, ownership of the claim and any contrary evidence. The associated decision question is: what supplier or open-source dependency could disrupt scaling?
Technical evaluations and founder interviews
Record the source, date, permission to use the material, ownership of the claim and any contrary evidence. The associated decision question is: which diligence findings are material to investment timing?
Where an input is an interview statement, a vendor claim or an internal estimate, it should be labelled as such. A research team may compare sources and expose an inconsistency, but it should not quietly convert a claim into a verified fact. Each finding should therefore carry a traceable citation or an explicit uncertainty note.
Research workstreamsQUESTION 01 QUESTION 02 QUESTION 03
Three questions to answer before committing
Is a technical differentiation claim supported?
A focused research workstream examines funding-stage technology disclosures, searches for relevant comparator evidence, and tests whether patent/technology competitor landscape is feasible. Findings are separated from assumptions and presented with a reviewer, date and suggested next action.
What supplier or open-source dependency could disrupt scaling?
A focused research workstream examines patent and product competitor sources, searches for relevant comparator evidence, and tests whether engineering-risk interview guide is feasible. Findings are separated from assumptions and presented with a reviewer, date and suggested next action.
Which diligence findings are material to investment timing?
A focused research workstream examines technical evaluations and founder interviews, searches for relevant comparator evidence, and tests whether evidence-linked opportunity memo is feasible. Findings are separated from assumptions and presented with a reviewer, date and suggested next action.
These workstreams are mutually informing but should not be conflated. An encouraging technical result may not resolve ownership; a documented ownership position may not demonstrate adoption; and a plausible commercial opportunity may still be subject to third-party permissions.
Decision-ready deliverablesOUTPUT 01 OUTPUT 02 OUTPUT 03
Illustrative consulting work products
Patent/technology competitor landscape
This is an illustrative, version-controlled research output for the venture capital firm decision. It should identify the evidence reviewed, material gaps, alternative interpretations, accountable reviewers and the next meeting or approval at which it will be used.
Engineering-risk interview guide
This is an illustrative, version-controlled research output for the venture capital firm decision. It should identify the evidence reviewed, material gaps, alternative interpretations, accountable reviewers and the next meeting or approval at which it will be used.
Evidence-linked opportunity memo
This is an illustrative, version-controlled research output for the venture capital firm decision. It should identify the evidence reviewed, material gaps, alternative interpretations, accountable reviewers and the next meeting or approval at which it will be used.
Acceptance test
Decision test: the opportunity memo isolates investment-critical assumptions, their current confidence and the experiment needed to disprove them.
Formats can include a dated memorandum, an evidence table, a workshop brief or a structured knowledge repository. The correct format depends on who will use it and how often the underlying evidence will change; it is not determined by document length alone.
Illustrative case
How the research might be used
A venture investor evaluates two robotics startups claiming similar proprietary systems. The assignment compares technical evidence and patent landscapes, not security pricing or securities advice
Hypothetical example only: no actual client, assignment result or measurable saving is represented here. A suitable engagement would first obtain authority to examine the relevant records, map conflicting stakeholder expectations and document what the evidence can establish without specialist determination.
Decision test: the opportunity memo isolates investment-critical assumptions, their current confidence and the experiment needed to disprove them. If the evidence fails that test, the responsible team should either revise the research question, commission a defined further check, or decline to proceed. A negative finding can be a valuable result when it prevents an irreversible commitment.
Engagement methodSTEP 01 STEP 02 STEP 03 STEP 04
Four-stage, reviewable research process
Define the decision
Agree who needs to decide, when, and how the venture capital firm case will be assessed. Exclude requests for advice outside the approved consulting scope.
Collect permitted evidence
Build a source register around funding-stage technology disclosures, patent and product competitor sources and technical evaluations and founder interviews. Record document provenance and separate public records from controlled or confidential information.
Compare and challenge
Evaluate the three research questions against alternative hypotheses; state the strength of evidence, disagreements and checks needed before accepting a conclusion.
Deliver and transfer
Provide the agreed work products with a methods note, reviewer assumptions, update triggers and a short decision workshop. Identify which matters must go to qualified independent advisers.
Where the work spans several countries, the source register should identify the jurisdiction of each proposition and the date it was checked. Documents and analysis that have not been legally reviewed must not be presented as binding conclusions.
Professional scope
What the consulting output does not certify
Founder interviews, independent benchmarks, patents and open-source records must be distinguished by evidentiary weight. Valuation and securities conclusions belong to appropriate advisers.
These pages describe technology research, IP intelligence, workflow design and commercial decision support. They are not offers to provide regulated legal representation across jurisdictions, securities recommendations, financial valuations, safety certification, medical opinions or governmental procurement determinations. Such work requires appropriate independent professionals and written engagement terms.
The enquiry process itself does not create a client relationship, guarantee confidentiality outside agreed arrangements, or authorize disclosure of third-party restricted documents. Submit only non-confidential context initially.
Sources and related research
Institutional reference and published site links
Primary institutional context: https://www.wipo.int/en/web/patent-analytics. This reference provides a research starting point; applicability to any specific assignment must be assessed independently.
Begin with the following published site resources when defining an initial brief. The links connect complementary research scopes rather than claiming that every topic is a confirmed professional service.
- All buyer solutions
- Consulting services
- Contact and project enquiry
- Venture Capital And Private Equity
- Patent Intelligence Competitive Research And Valuation
Document versions, relevant jurisdictions and the date of source verification should accompany decisions based on technical, legal, financial or policy materials.
Buyer FAQs
Questions to resolve before engagement
Is a technical differentiation claim supported?
The review starts from funding-stage technology disclosures and evaluates whether patent/technology competitor landscape would change the decision. Conflicting or incomplete evidence is recorded explicitly, and a responsible specialist reviews any regulated conclusion.
What supplier or open-source dependency could disrupt scaling?
The review starts from patent and product competitor sources and evaluates whether engineering-risk interview guide would change the decision. Conflicting or incomplete evidence is recorded explicitly, and a responsible specialist reviews any regulated conclusion.
Which diligence findings are material to investment timing?
The review starts from technical evaluations and founder interviews and evaluates whether evidence-linked opportunity memo would change the decision. Conflicting or incomplete evidence is recorded explicitly, and a responsible specialist reviews any regulated conclusion.
How would a venture capital firm start an enquiry?
Share the decision date, a short non-confidential description of the system or transaction and the intended research output. Sensitive documents should only be exchanged through an agreed confidential process.
Answers describe an illustrative research approach. Actual deliverables depend on reviewed source access, engagement terms and specialist requirements.
Project enquiry
Discuss a venture capital firm research question
Please share the decision, available source materials, countries or markets involved, the desired deliverable and the decision date. Do not attach confidential records before an appropriate intake is agreed.